BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33620145)

  • 21. Distal Femoral Non-Epiphyseal Cortical Chondroblastoma Confirmed with
    Gu H; Sun L; Cui J; Yu L; Wang J
    Fetal Pediatr Pathol; 2023 Apr; 42(2):320-326. PubMed ID: 36048092
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic Utility of Genetic and Immunohistochemical
    Wągrodzki M; Tysarowski A; Seliga K; Wojnowska A; Stepaniuk M; Castañeda Wysocka P; Makuła D; Pieńkowski A; Szostakowski B; Zub R; Rutkowski P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy.
    Rehkämper J; Steinestel K; Jeiler B; Elges S; Hekeler E; Huss S; Sperveslage J; Hardes J; Streitbürger A; Gosheger G; Wardelmann E; Baumhoer D; Trautmann M; Hartmann W
    Oncotarget; 2018 Jul; 9(53):30106-30114. PubMed ID: 30046391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chondroblastoma: Cytomorphologic Analysis of 10 Cases with Review of the Literature.
    Saoud C; Wakely PE; Pantanowitz L; Siddiqui MT; Ali SZ
    Acta Cytol; 2023; 67(4):413-424. PubMed ID: 36599325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases.
    Yang L; Zhang H; Zhang X; Tang Y; Wu Z; Wang Y; Huang H; Fu X; Liu J; Hogendoorn PCW; Cheng H
    Ann Diagn Pathol; 2022 Apr; 57():151882. PubMed ID: 34995868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
    Lu C; Jain SU; Hoelper D; Bechet D; Molden RC; Ran L; Murphy D; Venneti S; Hameed M; Pawel BR; Wunder JS; Dickson BC; Lundgren SM; Jani KS; De Jay N; Papillon-Cavanagh S; Andrulis IL; Sawyer SL; Grynspan D; Turcotte RE; Nadaf J; Fahiminiyah S; Muir TW; Majewski J; Thompson CB; Chi P; Garcia BA; Allis CD; Jabado N; Lewis PW
    Science; 2016 May; 352(6287):844-9. PubMed ID: 27174990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone Mutations and Bone Cancers.
    Taylor EL; Westendorf JJ
    Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
    Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
    Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability and Role of Mutation-specific H3F3A (Histone 3-3) G34W Immunohistochemistry to Differentiate Giant Cell Tumor of Bone From its Clinicoradiologic and Histologic Mimics: An Institutional Study.
    Pasricha S; Pruthi M; Jajodia A; Kumar A; Gupta G; Sharma A; Tiwari A; Rohela H; Durga G; Kamboj M; Koyyala VPB; Mehta A
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):36-41. PubMed ID: 34347625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
    Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign chondroblastoma on fine-needle aspiration smears: A seven-case experience and review of the literature.
    Cozzolino I; Zeppa P; Zabatta A; Merolla F; Vetrani A; Sadile F
    Diagn Cytopathol; 2015 Sep; 43(9):734-8. PubMed ID: 25914148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.
    Behjati S; Tarpey PS; Presneau N; Scheipl S; Pillay N; Van Loo P; Wedge DC; Cooke SL; Gundem G; Davies H; Nik-Zainal S; Martin S; McLaren S; Goodie V; Robinson B; Butler A; Teague JW; Halai D; Khatri B; Myklebost O; Baumhoer D; Jundt G; Hamoudi R; Tirabosco R; Amary MF; Futreal PA; Stratton MR; Campbell PJ; Flanagan AM
    Nat Genet; 2013 Dec; 45(12):1479-82. PubMed ID: 24162739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [DNA sequencing of H3F3A mutations in H3.3 immunohistochemistry-negative giant cell tumors of bone].
    Gong LH; Zhang W; Sun XQ; Zhang M; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):190-193. PubMed ID: 33677880
    [No Abstract]   [Full Text] [Related]  

  • 34. [The H3.3 K36M mutation protein expression of H3.3 in chondroblastoma: a novel diagnostic biomarker].
    Gong LH; Zhang W; Dong RF; Zhang TT; Sun XQ; Zhang M; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):242-244. PubMed ID: 33677889
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.
    Venneker S; Szuhai K; Hogendoorn PCW; Bovée JVMG
    Virchows Arch; 2020 Jan; 476(1):135-146. PubMed ID: 31728625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center.
    Rekhi B; Dave V; Butle A; Dutt A
    Ann Diagn Pathol; 2023 Oct; 66():152174. PubMed ID: 37356274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
    Ratnagiri R; Uppin S
    J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
    Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histones and their practical application in bone tumors: Do I always need them?
    Reith JD
    Hum Pathol; 2024 May; 147():92-100. PubMed ID: 38307341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.